Conclusion
The present meta-analysis has shown that it is an entirely effective
non-invasive treatment for uterine fibroids; this is evident by reducing
the overall NPV, tSSS% change, and decrease in the fibroid size. The
studies focussing on the impact of HrQoL are needed in this aspect. The
trials focusing on the reproductive outcomes should focus on the
recommendation of this therapy for uterine fibroids.
Acknowledgment: None Declared.
Statement of Ethics: All procedures performed in the study were in
accordance with the institutional and/or national research committee’s
standards and with the 1964 Helsinki declaration and its later
amendments or comparable ethical standards.
Conflict of Interest Statement: The authors declare that they have no
competing interests.
Funding Sources: No Funding was received.
Author Contributions: SZ and YR: Concept and designed the study, HZ and
XZ: analyzed data and drafting of the manuscript; XL and YW: Collected
the data and helped in data analysis; MZ: Proofreading and final editing
along with guarantor of the manuscript.
“All authors read and approved the final version of the manuscript”.